Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa.
Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa.
复制标题
用聚乙二醇干扰素α治疗丙型肝炎后,冷球蛋白血症相关血管炎持续恶化。
DOI:
10.1097/01.meg.0000108342.41221.0c
复制
发表时间:
2004
影响因子:
2.1
通讯作者:
L. Weiss
中科院分区:
文献类型:
--
作者:
D. Batisse;M. Karmochkine;C. Jacquot;M. Kazatchkine;L. Weiss
Peginterferon is now the gold standard of therapy in patients with chronic hepatitis C virus infection. Extrahepatic manifestations of HCV are usually treated with interferon alfa. Here we report on a patient with HCV-related cirrhosis and cryoglobulinaemia who presented with an acute and long-lasting exacerbation of vasculitis during treatment with peginterferon. To our knowledge this is the first report of an acute exacerbation of cryoglobulinaemia-related vasculitis involving skin, peripheral nerve and kidney in a patient treated with peginterferon for HCV-related cirrhosis. The long half-life of peginterferon might explain the long-lasting symptoms of vasculitis. Clinicians should be aware of possible sustained flare of cryoglobulinaemia-associated vasculitis in patients receiving peginterferon.